阿司匹林过敏:心脏病专家的实用指南
Silvia Grimaldi1, Paola Migliorini2, Ilaria Puxeddu2
1Postgraduate School of Cardiology, University of Pisa and Cardiovascular Division, Pisa University Hospital, Via Paradisa 2, 56124 Pisa, Italy.
European heart journal
|April 26, 2024
概括
阿司匹林对于预防心血管疾病至关重要,但过敏症限制了它的使用. 本综述探讨了阿司匹林过敏,其机制和管理,包括脱敏方案.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿司匹林是心血管疾病抗血栓治疗的基石.
- 在穿皮冠状动脉干预后的双重抗血小板治疗和假体门置换时,它是强制性的.
- 阿司匹林过敏影响0.6%-2.5%的人口,呈现出不同的临床表现.
研究的目的:
- 审查阿司匹林过敏症的流行病学,病理生理学和临床表现.
- 概述阿司匹林过敏症患者的管理选择.
- 将真正的阿司匹林过敏与不耐受性区分开来,并讨论脱敏方案.
主要方法:
- 流行病学,病理生理学,临床表现和阿司匹林过敏症管理的文献综述.
- 阿司匹林过敏与不耐受症的特征.
- 讨论对无敏化方案的讨论.
主要成果:
- 阿司匹林过敏症表现出广泛的症状,从呼吸道问题到过敏反应.
- 区分真正的过敏和不耐受性对于适当的管理至关重要.
- 脱敏方案为需要阿司匹林治疗的患者提供了可行的选择.
结论:
- 阿司匹林过敏症在心血管医学中构成了重大临床挑战.
- 准确的诊断和量身定制的管理,包括无敏化,对于避免遗漏这种重要药物至关重要.
- 对病理生理机制的进一步研究可以改进治疗策略.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Imaging Studies for Cardiovascular System I:Echocardiography
319
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
319
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
741
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
741


